Mount Sinai Researchers Build Models Using Machine Learning Technique to Enhance Predictions of COVID-19 Outcomes

Mount Sinai researchers have published one of the first studies using a machine learning technique called “federated learning” to examine electronic health records to better predict how COVID-19 patients will progress.

Story Tips from Johns Hopkins Experts on COVID-19

Vaccines take time to work. After getting a COVID-19 vaccine, it takes a while for the immune system to fully respond and provide protection from the virus. For the Moderna and Pfizer COVID-19 vaccines, it takes up to two weeks after the second shot to become appropriately protected.

Mount Sinai Researchers Build Models Using Machine Learning Technique to Enhance Predictions of COVID-19 Outcomes

Mount Sinai researchers have published one of the first studies using federated learning to examine electronic health records to better predict how COVID-19 patients will progress.

Jefferson Lab Launches Virtual AI Winter School for Physicists

Artificial intelligence is a game-changer in nuclear physics, able to enhance and accelerate fundamental research and analysis by orders of magnitude. DOE’s Jefferson Lab is exploring the expanding synergy between nuclear physics and computer science as it co-hosts together with The Catholic University of America and the University of Maryland a virtual weeklong series of lectures and hands-on exercises Jan. 11-15 for graduate students, postdoctoral researchers and even “absolute beginners.”

10 ways Argonne science is combatting COVID-19

Argonne scientists and research facilities have made a difference in the fight against COVID-19 in the year since the first gene sequence for the virus was published.

UCI researchers use deep learning to identify gene regulation at single-cell level

Irvine, Calif., Jan. 5, 2021 — Scientists at the University of California, Irvine have developed a new deep-learning framework that predicts gene regulation at the single-cell level. Deep learning, a family of machine-learning methods based on artificial neural networks, has revolutionized applications such as image interpretation, natural language processing and autonomous driving.

Machine Learning Improves Particle Accelerator Diagnostics

Operators of Jefferson Lab’s primary particle accelerator are getting a new tool to help them quickly address issues that can prevent it from running smoothly. The machine learning system has passed its first two-week test, correctly identifying glitchy accelerator components and the type of glitches they’re experiencing in near-real-time. An analysis of the results of the first field test of the custom-built machine learning system was recently published in the journal Physical Review Accelerators and Beams.

Developing Smarter, Faster Machine Intelligence with Light

SUMMARYResearchers at the George Washington University, together with researchers at the University of California, Los Angeles, and the deep-tech venture startup Optelligence LLC, have developed an optical convolutional neural network accelerator capable of processing large amounts of information, on the…

UCI researchers create model to calculate COVID-19 health outcomes

Irvine, Calif., Dec. 17, 2020 —University of California, Irvine health sciences researchers have created a machine-learning model to predict the probability that a COVID-19 patient will need a ventilator or ICU care. The tool is free and available online for any healthcare organization to use. “The goal is to give an earlier alert to clinicians to identify patients who may be vulnerable at the onset,” said Daniel S.

Artificial Intelligence Advances Showcased at the Virtual 2020 AACC Annual Scientific Meeting Could Help to Integrate This Technology Into Everyday Healthcare

Artificial intelligence (AI) has the potential to revolutionize healthcare, but integrating AI-based techniques into routine medical practice has proven to be a significant challenge. A plenary session at the virtual 2020 AACC Annual Scientific Meeting & Clinical Lab Expo will explore how one clinical lab overcame this challenge to implement a machine learning-based test, while a second session will take a big picture look at what machine learning is and how it could transform medicine.

Synthetic Biology and Machine Learning Speed the Creation of Lab-Grown Livers

Researchers at the University of Pittsburgh School of Medicine have combined synthetic biology with a machine learning algorithm to create human liver organoids with blood and bile handling systems. When implanted into mice with failing livers, the lab-grown replacement livers extended life.

Automatic deep-learning, artificial-intelligence clinical tool that can measure the volume of cerebral ventricles on MRIs in children

Researchers from multiple institutions in North America have developed a fully automated, deep-learning (DL), artificial-intelligence clinical tool that can measure the volume of cerebral ventricles on magnetic resonance images (MRIs) in children within about 25 minutes.

Argonne AI methods unravel mysteries of SARS-CoV-2 viral-human cell interaction

Using a combination of AI and supercomputing resources, Argonne researchers are examining the dynamics of the SARS-CoV-2 spike protein to determine how it fuses with the human host cell, advancing the search for drug treatments.

Virtual reality: ALCF’s remote interns tackle real-world computing projects

The Argonne Leadership Computing Facility’s internship program went virtual this year, providing students with an opportunity to work on real-world research projects that address issues at the forefront of scientific computing.

New Machine Learning-Based Model More Accurately Predicts Liver Transplant Waitlist Mortality

Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that using neural networks, a type of machine learning algorithm, is a more accurate model for predicting waitlist mortality in liver transplantation, outperforming the older model for end-stage liver disease (MELD) scoring. This advancement could lead to the development of more equitable organ allocation systems and even reduce liver transplant waitlist death rates for patients.

Mount Sinai Develops Machine Learning Models to Predict Critical Illness and Mortality in COVID-19 Patients

Mount Sinai researchers have developed machine learning models that predict the likelihood of critical events and mortality in COVID-19 patients within clinically relevant time windows.

Biologists Create “Atlas” of Gene Expression in Neurons, Documenting the Diversity of Brain Cells

New York University researchers have created a “developmental atlas” of gene expression in neurons, using gene sequencing and machine learning to categorize more than 250,000 neurons in the brains of fruit flies. Their study, published in Nature, finds that neurons exhibit the most molecular diversity during development and reveals a previously unknown type of neurons only present before flies hatch.

Informatics Approach Helps Reveal Risk Factors for Pressure Injuries

Researchers used informatics to examine 5,000+ patient records and five years of data related to nursing skin assessments and hospital-acquired pressure injuries. The results underscore the importance of treating and monitoring irritated skin early and eliminating the cause as an important step to prevent pressure injuries.

AI gets a boost via LLNL, SambaNova collaboration

Lawrence Livermore National Laboratory (LLNL) has installed a state-of-the-art artificial intelligence (AI) accelerator from SambaNova Systems, the National Nuclear Security Administration (NNSA) announced today, allowing researchers to more effectively combine AI and machine learning (ML) with complex scientific workloads.

Creating the software that will unlock the power of exascale

Researchers nationwide are building the software and applications that will run on some the world’s fastest supercomputers. Among them are members of DOE’s Exascale Computing Project who recently published a paper highlighting their progress so far.

Scientists voice concerns, call for transparency and reproducibility in AI research

In an article published in Nature on October 14, 2020, scientists at Princess Margaret Cancer Centre, University of Toronto, Stanford University, Johns Hopkins, Harvard School of Public Health, Massachusetts Institute of Technology, and others, challenge scientific journals to hold computational researchers to higher standards of transparency, and call for their colleagues to share their code, models and computational environments in publications.

Assessing State of the Art in AI for Brain Disease Treatment

The range of AI technologies available for dealing with brain disease is growing fast, and exciting new methods are being applied to brain problems as computer scientists gain a deeper understanding of the capabilities of advanced algorithms. In APL Bioengineering, Italian researchers conducted a systematic literature review to understand the state of the art in the use of AI for brain disease. Their qualitative review sheds light on the most interesting corners of AI development.

Unraveling the network of molecules that influence COVID-19 severity

Researchers from the Morgridge Institute for Research, the University of Wisconsin-Madison, and Albany Medical College have identified more than 200 molecular features that strongly correlate with COVID-19 severity, offering insight into potential treatment options for those with advanced disease.

Virtual Argonne training program prepares researchers for extreme-scale computing

The annual Argonne Training Program on Extreme-Scale Computing went virtual this year, providing two weeks of instruction to ready attendees for science in the exascale era.

The Future of Precision Medicine

Precision medicine is a rapidly growing approach to health care that focuses on finding treatments and interventions that work for people based on their genetic makeup, rather than their symptoms.

Zeeshan Ahmed, director of the new Ahmed Lab at Rutgers Institute for Health, Health Care Policy and Aging Research, discusses the future of precision medicine, what needs to be done to successfully analyze the data necessary to develop individualized treatments and the role genetics play during the COVID-19 pandemic.